Immunogenic death of colon cancer cells treated with oxaliplatin
Both the pre-apoptotic exposure of calreticulin (CRT) and the post-apoptotic release of high-
mobility group box 1 protein (HMGB1) are required for immunogenic cell death elicited by …
mobility group box 1 protein (HMGB1) are required for immunogenic cell death elicited by …
[PDF][PDF] Immunogenic death of colon cancer cells treated with oxaliplatin
A Tesniere, F Schlemmer, V Boige, O Kepp, I Martins… - Oncogene, 2010 - researchgate.net
Conventional anticancer chemotherapy or radiotherapy is generally thought to reduce tumor
progression by direct cytostatic and cytotoxic effects on tumor cells. Although this paradigm …
progression by direct cytostatic and cytotoxic effects on tumor cells. Although this paradigm …
Immunogenic death of colon cancer cells treated with oxaliplatin.
A Tesniere, F Schlemmer, V Boige, O Kepp, I Martins… - Oncogene, 2009 - europepmc.org
Both the pre-apoptotic exposure of calreticulin (CRT) and the post-apoptotic release of high-
mobility group box 1 protein (HMGB1) are required for immunogenic cell death elicited by …
mobility group box 1 protein (HMGB1) are required for immunogenic cell death elicited by …
Immunogenic death of colon cancer cells treated with oxaliplatin
A Tesniere, F Schlemmer, V Boige, O Kepp… - …, 2010 - pubmed.ncbi.nlm.nih.gov
Both the pre-apoptotic exposure of calreticulin (CRT) and the post-apoptotic release of high-
mobility group box 1 protein (HMGB1) are required for immunogenic cell death elicited by …
mobility group box 1 protein (HMGB1) are required for immunogenic cell death elicited by …
[引用][C] Immunogenic death of colon cancer cells treated with oxaliplatin
A TESNIERE, F SCHLEMMER… - Oncogene …, 2010 - pascal-francis.inist.fr
Author TESNIERE, A 1 2 3; SCHLEMMER, F 1 2 3; MENDIBOURE, J 10 2; PIGNON, J.-P 10
2; JOOSTE, V 11 9; VAN ENDERT, P 12; DUCREUX, M 2 3 4; ZITVOGEL, L 13 2 3 7; PIARD …
2; JOOSTE, V 11 9; VAN ENDERT, P 12; DUCREUX, M 2 3 4; ZITVOGEL, L 13 2 3 7; PIARD …
[PDF][PDF] Immunogenic death of colon cancer cells treated with oxaliplatin
A Tesniere, F Schlemmer, V Boige, O Kepp, I Martins… - Oncogene, 2010 - academia.edu
Conventional anticancer chemotherapy or radiotherapy is generally thought to reduce tumor
progression by direct cytostatic and cytotoxic effects on tumor cells. Although this paradigm …
progression by direct cytostatic and cytotoxic effects on tumor cells. Although this paradigm …
Immunogenic death of colon cancer cells treated with oxaliplatin.
A Tesniere, F Schlemmer, V Boige, O Kepp… - …, 2010 - search.ebscohost.com
Both the pre-apoptotic exposure of calreticulin (CRT) and the post-apoptotic release of high-
mobility group box 1 protein (HMGB1) are required for immunogenic cell death elicited by …
mobility group box 1 protein (HMGB1) are required for immunogenic cell death elicited by …
Immunogenic death of colon cancer cells treated with oxaliplatin
A Tesniere, F Schlemmer, V Boige, O Kepp, I Martins… - Oncogene, 2010 - go.gale.com
Both the pre-apoptotic exposure of calreticulin (CRT) and the post-apoptotic release of high-
mobility group box 1 protein (HMGB1) are required for immunogenic cell death elicited by …
mobility group box 1 protein (HMGB1) are required for immunogenic cell death elicited by …
[引用][C] Immunogenic death of colon cancer cells treated with oxaliplatin
A Tesniere, F Schlemmer, V Boige, O Kepp, I Martins… - Oncogene, 2009 - cir.nii.ac.jp
Immunogenic death of colon cancer cells treated with oxaliplatin | CiNii Research CiNii 国立
情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす …
情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす …